Multi-Targeted Cardiac Risk Intervention in Type 2 Diabetes
| Status: | Completed |
|---|---|
| Conditions: | High Blood Pressure (Hypertension), High Cholesterol, Diabetes |
| Therapuetic Areas: | Cardiology / Vascular Diseases, Endocrinology |
| Healthy: | No |
| Age Range: | 18 - 85 |
| Updated: | 5/3/2014 |
| Start Date: | October 2006 |
| End Date: | June 2008 |
| Contact: | Wen-Chih Wu, MD |
| Email: | wen-chih.wu@va.gov |
| Phone: | 401-273-7100 |
Our study intends to test the efficacy of pharmacist-led group interventions on a weekly
basis for 4-weeks, then on a monthly basis for 5 additional months to achieve concomitant
reductions in hemoglobin A1c, lipids and blood pressure.
basis for 4-weeks, then on a monthly basis for 5 additional months to achieve concomitant
reductions in hemoglobin A1c, lipids and blood pressure.
Our project intends to study the 6-month efficacy of a pharmacist-led group intervention
program that simultaneously target diabetes, hypertension and dyslipidemia. We hypothesize
that pharmacist-led group interventions on a weekly basis for 4-weeks then on a monthly
basis for 5 additional months may achieve concomitant reductions in hemoglobin A1c, lipids
and blood pressure. We are proposing a pilot randomized controlled study to test the
efficacy and feasibility of this approach.
program that simultaneously target diabetes, hypertension and dyslipidemia. We hypothesize
that pharmacist-led group interventions on a weekly basis for 4-weeks then on a monthly
basis for 5 additional months may achieve concomitant reductions in hemoglobin A1c, lipids
and blood pressure. We are proposing a pilot randomized controlled study to test the
efficacy and feasibility of this approach.
Inclusion Criteria:
- type 2 diabetes mellitus,
- >18 years old,
- with a documented HbA1c more than 7.0%,
- an LDL cholesterol >100 mg/dl AND a blood pressure >130/80 mm Hg documented at least
once in the medical records within the last 6 months, and
- willing to comply with the study interventions will be eligible for the study.
Exclusion Criteria:
- pregnancy,
- unable to attend the group sessions,
- disease conditions such as psychiatric instability (acutely suicidal, psychotic) or
organic brain injury that preclude them from performing diabetes self-care,
- enrolled in the Providence VAMC's Telehealth program
We found this trial at
1
site
Click here to add this to my saved trials
